3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Leukemia, Myeloid, Acute
117
Myelodysplastic Syndromes
73
Leukemia, Myelomonocytic, Chronic
34
Leukemia
30
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Myeloproliferative Disorders
8
Lymphoma, Non-Hodgkin
8
Lymphoma
8
Leukemia, Myelomonocytic, Acute
8
Congenital Abnormalities
8
Recurrence
7
Multiple Myeloma
7
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Leukemia, Monocytic, Acute
6
Leukemia, Erythroblastic, Acute
6
Primary Myelofibrosis
5
Lung Neoplasms
5
Leukemia, Megakaryoblastic, Acute
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Hematologic Neoplasms
5
Anemia, Refractory, with Excess of Blasts
5
Prostatic Neoplasms
4
Myelodysplastic-Myeloproliferative Diseases
4
Melanoma
4
Lymphoma, Follicular
4
Pancreatic Neoplasms
3
Interventions
Radiotherapy
83
Temozolomide
78
Filgrastim
34
Carboplatin
33
Vincristine
29
Etoposide
26
Cyclophosphamide
25
Carmustine
25
Irinotecan
23
Chemotherapy, Adjuvant
23
Cisplatin
21
Peripheral Blood Stem Cell Transplantation
20
Thiotepa
14
Lomustine
14
Granulocyte Colony-Stimulating Factor
13
Surgical Procedures, Operative
12
Procarbazine
12
Bevacizumab
11
Thalidomide
10
O(6)-benzylguanine
10
Drug Therapy
10
etoposide phosphate
9
Methotrexate
9
Magnetic Resonance Spectroscopy
9
Gene Expression Profiling
9
Radiation
8
Paclitaxel
8
sargramostim
7
Ifosfamide
7
Everolimus
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Central Nervous System Neoplasms
×
Azacitidine
×
Clear all
NCT03206021
2024-04-05
COZMOS
The Hospital for Sick Children
Phase 1
Completed
31 enrolled